Hong Kong gold push delivers record US$732 million ETF inflows in April


Hong Kong’s push to become a gold trading hub is beginning to bear fruit, with the city recording a surge in gold exchange-traded fund (ETF) inflows in April as geopolitical tensions fuel investor demand for the yellow metal, according to industry participants.

Physically backed gold ETFs in Hong Kong attracted a record US$732 million last month, according to the World Gold Council. That represented 41 per cent of Asia’s US$1.8 billion inflows and 11 per cent of the global total of US$6.6 billion.

The CSOP Gold ETF, which listed in April on the Hong Kong stock exchange, debuted with assets under management of about US$720 million, making it the city’s largest local physical gold ETF to date.

Five gold ETFs with combined assets of HK$28 billion (US$3.6 billion) were listed as of April, exchange data showed. These products give investors a straightforward way to trade gold, much like buying and selling stocks.

The CSOP Gold ETF directly holds 4.7 tonnes of physical gold stored in Hong Kong, offering investors the option to redeem bullion. The development highlights the need for the city to expand storage capacity to support trading of more gold products.

The US and Israel war with Iran has prompted more traders to move from Dubai to Hong Kong. Photo: AFP
The US and Israel war with Iran has prompted more traders to move from Dubai to Hong Kong. Photo: AFP

Hong Kong Chief Executive John Lee Ka-chiu set a three-year goal in his 2025 policy address to help the Airport Authority and financial firms establish facilities for more than 2,000 tonnes of gold. A central gold clearing system is expected to start later this year, while Hong Kong Exchanges and Clearing (HKEX) plans to relaunch gold futures in the coming months as a hedging tool for investors.

  • Related Posts

    Brazil’s visa-free entry for Chinese visitors sparks rise in South America travel demand

    Travel agencies are seeing a notable rise in inquiries and bookings for trips to South America by tourists from mainland China after Brazil’s visa-free entry policy for visitors from the…

    Continue reading
    China’s Hengrui seals US$15.2 billion deal with US pharmaceutical giant BMS

    Jiangsu Hengrui Pharmaceutical, China’s largest drug company by market capitalisation, has signed a global collaboration and licensing agreement with US pharmaceutical giant Bristol Myers Squibb (BMS) worth up to US$15.2…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *